Xing Li
Pingxiang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Tegoprazan-based versus esomeprazole-based triple therapy plus bismuth for first-line Helicobacter pylori eradication: A nationwide, multicenter, double-blind, double-dummy, randomized controlled trial.
Journal: Chinese medical journal
Published: March 28, 2025
Correlation between the type of esophagogastric junction and refractory reflux esophagitis.
Journal: International journal of clinical and experimental pathology
Published: March 17, 2025
Efficacy and safety of tegoprazan for duodenal ulcers in Chinese patients: a multicenter, randomized, double-blind, non-inferiority, phase III study.
Journal: Current medical research and opinion
Published: October 08, 2024
A Randomized, Comparative Trial of a Potassium-Competitive Acid Blocker (X842) and Lansoprazole for the Treatment of Patients With Erosive Esophagitis.
Journal: Clinical and translational gastroenterology
Published: July 26, 2024
The efficacy of keverprazan-based quadruple therapy for Helicobacter pylori eradication: A phase III, randomised, double-blind, multicentre trial.
Journal: International journal of antimicrobial agents
Published: April 10, 2024
Efficacy and safety of tegoprazan (LXI-15028) vs . esomeprazole in patients with erosive esophagitis: A multicenter, randomized, double-blind, non-inferiority phase Ⅲ trial.
Journal: Chinese medical journal
Published: March 29, 2024
The efficacy and safety of fexuprazan in treating erosive esophagitis: a phase III, randomized, double-blind, multicenter study.
Journal: Journal of gastroenterology and hepatology
Published: September 30, 2023
Efficacy of image-enhanced endoscopy for colorectal adenoma detection: A multicenter, randomized trial.
Journal: World journal of gastrointestinal oncology
Published: December 05, 2022
Efficacy and Safety of Keverprazan Compared With Lansoprazole in the Treatment of Duodenal Ulcer: A Phase III, Randomized, Double-Blind, Multicenter Trial.
Journal: Clinical and translational gastroenterology
Published: September 18, 2022
SPI1 Mediates N-Myristoyltransferase 1 to Advance Gastric Cancer Progression via PI3K/AKT/mTOR Pathway.
Journal: Canadian journal of gastroenterology & hepatology
Published: September 13, 2022
The efficacy and safety of keverprazan, a novel potassium-competitive acid blocker, in treating erosive oesophagitis: a phase III, randomised, double-blind multicentre study.
Journal: Alimentary pharmacology & therapeutics
Published: February 21, 2022
Last Updated: 09/26/2026